Macêdo Priscila Tavares, Aquino Antônio C Q, Meurer Ywlliane S R, Brandão Luiz E M, Campêlo Clarissa L C, Lima Ramon H, Costa Marcos R, Ribeiro Alessandra M, Silva Regina H
Memory Studies Laboratory, Physiology Department, Universidade Federal do Rio Grande do Norte, Natal, Brazil.
Brain Institute, Universidade Federal do Rio Grande do Norte, Natal, Brazil.
Front Aging Neurosci. 2018 Jan 30;10:18. doi: 10.3389/fnagi.2018.00018. eCollection 2018.
The cause of Alzheimer's disease (AD) remains uncertain. The accumulation of amyloid peptides (Aβ) is the main pathophysiological hallmark of the disease. Spatial deficit is an important initial sign of AD, while other types of memory impairments that appear in later stages. The Barnes maze allows the detection of subtle alterations in spatial search by the analysis of use of different strategies. Previous findings showed a general performance deficit in this task following long-term (35 days) infusion of Aβ, which corresponds to the moderate or severe impairments of the disease. In the present study, we evaluated the effects of a low-dose 15-day long treatment with Aβ peptides on spatial and non-spatial strategies of rats tested in the Barnes maze. Aβ peptides (0.5 μL/site/day; 30 pmoL solution of Aβ1-40:Aβ1-42 10:1) or saline were bilaterally infused into the CA1 (on the first treatment day) and intraventricularly (on the following 15 days) in 6-month-old Wistar male rats. Aβ infusion induced a deficit in the performance (increased latency and distance traveled to reach the target compared to saline group). In addition, a significant association between treatment and search strategy in the retrieval trial was found: Aβ group preferred the non-spatial search strategy, while saline group preferred the spatial search. In conclusion, the protocol of Aβ infusion used here induced a subtle cognitive deficit that was specific to spatial aspects. Indeed, animals under Aβ treatment still showed retrieval, but using non-spatial strategies. We suggest that this approach is potentially useful to the study of the initial memory deficits in early AD.
阿尔茨海默病(AD)的病因仍不明确。淀粉样肽(Aβ)的积累是该疾病主要的病理生理特征。空间缺陷是AD的一个重要初始迹象,而其他类型的记忆障碍则出现在疾病后期。巴恩斯迷宫可通过分析不同策略的使用情况来检测空间搜索中的细微变化。先前的研究结果表明,长期(35天)注入Aβ后,该任务的总体表现会出现缺陷,这与疾病的中度或重度损伤相对应。在本研究中,我们评估了低剂量15天的Aβ肽治疗对在巴恩斯迷宫中测试的大鼠空间和非空间策略的影响。将Aβ肽(0.5 μL/部位/天;Aβ1-40:Aβ1-42比例为10:1的30 pmol溶液)或生理盐水双侧注入6月龄雄性Wistar大鼠的CA1区(在首次治疗日),并在接下来的15天内进行脑室内注射。注入Aβ导致表现出现缺陷(与生理盐水组相比,达到目标的潜伏期和行进距离增加)。此外,在检索试验中发现治疗与搜索策略之间存在显著关联:Aβ组更喜欢非空间搜索策略,而生理盐水组更喜欢空间搜索。总之,这里使用的Aβ注入方案诱发了一种特定于空间方面的细微认知缺陷。实际上,接受Aβ治疗的动物仍表现出检索能力,但使用的是非空间策略。我们认为这种方法可能有助于研究早期AD的初始记忆缺陷。